Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 13
Breast Cancer: Targets and Therapy
- View all (362)
- Volume 14, 2022 (11)
- Volume 13, 2021 (58)
- Volume 12, 2020 (27)
- Volume 11, 2019 (32)
- Volume 10, 2018 (24)
- Volume 9, 2017 (64)
- Volume 8, 2016 (26)
- Volume 7, 2015 (36)
- Volume 6, 2014 (20)
- Volume 5, 2013 (13)
- Volume 4, 2012 (22)
- Volume 3, 2011 (16)
- Volume 2, 2010 (9)
- Volume 1, 2009 (4)
Archive: Volume 13, 2021
Effect of Heparinoid Moisturizer on Quality of Life in Patients with Acute Radiation Skin Damage Following Hypofractionated Radiation Therapy After Breast-Conserving Surgery: A Randomized Controlled Study
Kawamori J, Itazawa T, Fukushima S, Ito R, Yamauchi H, Sekiguchi K
Breast Cancer: Targets and Therapy 2021, 13:743-753
Published Date: 31 December 2021
Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions
Li D, Fan H, Dong J, Sun C, Su Y, Liu J, Gu Y
Breast Cancer: Targets and Therapy 2021, 13:725-742
Published Date: 23 December 2021
Systematic Review of Breast-Q: A Tool to Evaluate Post-Mastectomy Breast Reconstruction
Seth I, Seth N, Bulloch G, Rozen WM, Hunter-Smith DJ
Breast Cancer: Targets and Therapy 2021, 13:711-724
Published Date: 16 December 2021
Treatment and Survivorship Interventions to Prevent Poor Body Image Outcomes in Breast Cancer Survivors
Fiser C, Crystal JS, Tevis SE, Kesmodel S, Rojas KE
Breast Cancer: Targets and Therapy 2021, 13:701-709
Published Date: 16 December 2021
Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment
Kaur S, Najm MZ, Khan MA, Akhter N, Shingatgeri VM, Sikenis M, Sadaf, Aloliqi AA
Breast Cancer: Targets and Therapy 2021, 13:691-700
Published Date: 14 December 2021
Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis
Elakkad YE, Mohamed SNS, Abuelezz NZ
Breast Cancer: Targets and Therapy 2021, 13:675-689
Published Date: 14 December 2021
Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
Klauser AL, Hirschfeld M, Ritter A, Rücker G, Jäger M, Gundarova J, Weiss D, Juhasz-Böss I, Berner K, Erbes T, Asberger J
Breast Cancer: Targets and Therapy 2021, 13:659-673
Published Date: 8 December 2021
Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay
Castillo C, Camejo N, Rondan M, Savio F, Herrera G, Krygier G, Delgado L
Breast Cancer: Targets and Therapy 2021, 13:651-658
Published Date: 6 December 2021
Young Women with Breast Cancer in Resource-Limited Settings: What We Know and What We Need to Do Better
Martinez-Cannon BA, Barragan-Carrillo R, Villarreal-Garza C
Breast Cancer: Targets and Therapy 2021, 13:641-650
Published Date: 2 December 2021
Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
Butani D, Gupta N, Jyani G, Bahuguna P, Kapoor R, Prinja S
Breast Cancer: Targets and Therapy 2021, 13:625-640
Published Date: 27 November 2021
Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay
Meijer SE, Klebanov-Akopyn O, Pavlov V, Laks S, Hazzan D, Nissan A, Zippel D
Breast Cancer: Targets and Therapy 2021, 13:617-624
Published Date: 16 November 2021
Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution Study
Ayoub NM, Fares M, Marji R, Al Bashir SM, Yaghan RJ
Breast Cancer: Targets and Therapy 2021, 13:603-615
Published Date: 13 November 2021
How Does Patient Socioeconomic Position Affect Breast Cancer Surgical Treatment and Mortality?: A Rapid Review
Schubbe D, Yen RW, Durand MA
Breast Cancer: Targets and Therapy 2021, 13:595-601
Published Date: 27 October 2021
Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics
Lengfeld J, Zhang H, Stoesz S, Murali R, Pass F, Greene MI, Goel PN, Grover P
Breast Cancer: Targets and Therapy 2021, 13:575-593
Published Date: 14 October 2021
Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers
Al-saraireh YM, Alshammari FOFO, Youssef AM, Al-Tarawneh F, Al-Sarayreh S, Almuhaisen GH, Satari AO, Al-Shuneigat J, Alrawashdeh HM
Breast Cancer: Targets and Therapy 2021, 13:565-574
Published Date: 5 October 2021
Breast Self-Examination Practice and Associated Factors Among Women Attending Family Planning Service in Modjo Public Health Facilities Southwest Ethiopia [Response To Letter]
Asmare Adella G
Breast Cancer: Targets and Therapy 2021, 13:561-563
Published Date: 4 October 2021
Breast Self-Examination Practice and Associated Factors Among Women Attending Family Planning Service in Modjo Public Health Facilities Southwest Ethiopia [Letter]
MacKenzie A
Breast Cancer: Targets and Therapy 2021, 13:559-560
Published Date: 27 September 2021
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer
Salkeni MA, Rizvi W, Hein K, Higa GM
Breast Cancer: Targets and Therapy 2021, 13:539-557
Published Date: 24 September 2021
TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration
Wardhani BWK, Louisa M, Watanabe Y, Setiabudy R, Kato M
Breast Cancer: Targets and Therapy 2021, 13:529-538
Published Date: 21 September 2021
Diagnosis and Individualized Treatment of Three Primary Malignant Tumors: A Case Report
He F, Xia Y, Ling X
Breast Cancer: Targets and Therapy 2021, 13:519-527
Published Date: 9 September 2021
Does the Presence of Cytokeratin Positive Individual Tumor Cells (N0(I+)) in Sentinel Lymph Nodes Affect Clinical Outcomes in Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation
Smith J, Leonard C, Carter DL, Tole S
Breast Cancer: Targets and Therapy 2021, 13:513-517
Published Date: 29 August 2021
Screening a Solitary Dilated Duct in the Breast: A Pictorial Essay
Ayres VJ, Ramalho LC, Wludarski SCL, Fleury EDFC
Breast Cancer: Targets and Therapy 2021, 13:505-512
Published Date: 12 August 2021
Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action
Yap KM, Sekar M, Seow LJ, Gan SH, Bonam SR, Mat Rani NNI, Lum PT, Subramaniyan V, Wu YS, Fuloria NK, Fuloria S
Breast Cancer: Targets and Therapy 2021, 13:471-503
Published Date: 13 September 2021
Breast Self-Examination Practice and Associated Factors Among Women Attending Family Planning Service in Modjo Public Health Facilities Southwest Ethiopia
Urga Workineh M, Alem Lake E, Asmare Adella G
Breast Cancer: Targets and Therapy 2021, 13:459-469
Published Date: 27 July 2021
Antiproliferation Activity and Apoptotic Mechanism of Soursop (Annona muricata L.) Leaves Extract and Fractions on MCF7 Breast Cancer Cells
Hadisaputri YE, Habibah U, Abdullah FF, Halimah E, Mutakin M, Megantara S, Abdulah R, Diantini A
Breast Cancer: Targets and Therapy 2021, 13:447-457
Published Date: 16 July 2021
Therapeutic Role of Annona muricata Fruit and Bee Venom Against MNU-Induced Breast Cancer in Pregnant Rats and its Complications on the Ovaries
El-Beltagy AEFBM, Elsyyad HIH, Abdelaziz KK, Madany AS, Elghazaly MM
Breast Cancer: Targets and Therapy 2021, 13:431-445
Published Date: 8 July 2021
Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth
Kanzaki H, Chatterjee A, Hossein Nejad Ariani H, Zhang X, Chung S, Deng N, Ramanujan VK, Cui X, Greene MI, Murali R
Breast Cancer: Targets and Therapy 2021, 13:419-430
Published Date: 5 July 2021
Ductal Carcinoma in situ: Underestimation of Percutaneous Biopsy and Positivity of Sentinel Lymph Node Biopsy in a Brazilian Public Hospital
Sá RS, Logullo AF, Elias S, Facina G, Sanvido VM, Nazário ACP
Breast Cancer: Targets and Therapy 2021, 13:409-417
Published Date: 21 June 2021
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data
Jagosky M, Tan AR
Breast Cancer: Targets and Therapy 2021, 13:393-407
Published Date: 14 June 2021
Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study
Wako Z, Mengistu D, Dinegde NG, Asefa T, Wassie M
Breast Cancer: Targets and Therapy 2021, 13:383-392
Published Date: 9 June 2021
Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib
Ulrich L, Okines AF
Breast Cancer: Targets and Therapy 2021, 13:361-381
Published Date: 26 May 2021
Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer
Savioli F, Seth S, Morrow E, Doughty J, Stallard S, Malyon A, Romics L
Breast Cancer: Targets and Therapy 2021, 13:353-359
Published Date: 25 May 2021
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women
Martelli V, Latocca MM, Ruelle T, Perachino M, Arecco L, Beshiri K, Razeti MG, Tagliamento M, Cosso M, Fregatti P, Lambertini M
Breast Cancer: Targets and Therapy 2021, 13:341-351
Published Date: 24 May 2021
Analysis of Increased EGFR and IGF-1R Signaling and Its Correlation with Socio-Epidemiological Features and Biological Profile in Breast Cancer Patients: A Study in Northern Brazil
Silva Rocha F, da Silva Maués JH, Brito Lins Pereira CM, Moreira-Nunes CA, Rodriguez Burbano RM
Breast Cancer: Targets and Therapy 2021, 13:325-339
Published Date: 21 May 2021
Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound
Chen MY, Gillanders WE
Breast Cancer: Targets and Therapy 2021, 13:311-323
Published Date: 17 May 2021
Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?
Lazzari G, Buono G, Zannino B, Silvano G
Breast Cancer: Targets and Therapy 2021, 13:299-310
Published Date: 12 May 2021
Effectiveness of Psycho-Education Intervention Programme on Coping Strategies Among Jordanian Women Diagnosed with Breast Cancer: A Randomised Controlled Trial
Younis M, Norsa'adah B, Othman A
Breast Cancer: Targets and Therapy 2021, 13:285-297
Published Date: 11 May 2021
Cysteine Cathepsins and Matrix Metalloproteases Among Breast Cancer Patients
Tsegaye S, Mehdi M, Lako WL, Melka DS
Breast Cancer: Targets and Therapy 2021, 13:271-283
Published Date: 7 May 2021
Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis
Vyas A, Gabriel M, Kurian S
Breast Cancer: Targets and Therapy 2021, 13:259-269
Published Date: 13 April 2021
A Review of Modifiable Risk Factors in Young Women for the Prevention of Breast Cancer
Daly AA, Rolph R, Cutress RI, Copson ER
Breast Cancer: Targets and Therapy 2021, 13:241-257
Published Date: 13 April 2021
Jawbone Cavitation Expressed RANTES/CCL5: Case Studies Linking Silent Inflammation in the Jawbone with Epistemology of Breast Cancer
Lechner J, Schulz T, Lejeune B, von Baehr V
Breast Cancer: Targets and Therapy 2021, 13:225-240
Published Date: 9 April 2021
Association of Endocrine Therapy and Dementia in Women with Breast Cancer
Thompson MR, Niu J, Lei X, Nowakowska M, Wehner MR, Giordano SH, Nead KT
Breast Cancer: Targets and Therapy 2021, 13:219-224
Published Date: 7 April 2021
The Proper Ki-67 Cut-Off in Hormone Responsive Breast Cancer: A Monoinstitutional Analysis with Long-Term Follow-Up
Lombardi A, Lazzeroni R, Bersigotti L, Vitale V, Amanti C
Breast Cancer: Targets and Therapy 2021, 13:213-217
Published Date: 7 April 2021
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
Hyder T, Bhattacharya S, Gade K, Nasrazadani A, Brufsky AM
Breast Cancer: Targets and Therapy 2021, 13:199-211
Published Date: 30 March 2021
Identifying Risk Factors of Breast Cancer Among Women Attending Selected Hospitals of Addis Ababa City: Hospital-Based Unmatched Case-Control Study
Duche H, Tsegay AT, Tamirat KS
Breast Cancer: Targets and Therapy 2021, 13:189-197
Published Date: 12 March 2021
FOXQ1 is Differentially Expressed Across Breast Cancer Subtypes with Low Expression Associated with Poor Overall Survival
Elian FA, Are U, Ghosh S, Nuin P, Footz T, McMullen TPW, Brindley DN, Walter MA
Breast Cancer: Targets and Therapy 2021, 13:171-188
Published Date: 1 March 2021
An Update on the Molecular Pathology of Metaplastic Breast Cancer
McCart Reed AE, Kalaw EM, Lakhani SR
Breast Cancer: Targets and Therapy 2021, 13:161-170
Published Date: 26 February 2021
Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review
Linehan AS, Fitzpatrick OM, Morris PG
Breast Cancer: Targets and Therapy 2021, 13:151-159
Published Date: 25 February 2021
Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective
Yuan P, Xu B
Breast Cancer: Targets and Therapy 2021, 13:135-150
Published Date: 24 February 2021
Breast Cancer Screening Practice and Associated Factors Among Women Aged 20–70 Years in Urban Settings of SNNPR, Ethiopia [Corrigendum]
Assefa AA, Abera G, Geta M
Breast Cancer: Targets and Therapy 2021, 13:133-134
Published Date: 22 February 2021
The Impact of AC and AC-T Chemotherapy’s Toxicities on Quality of Life Among Women with Breast Cancer in Ethiopia: A Prospective Patient-Reported Outcomes Study
Gadisa DA, Wang SH, Yimer G
Breast Cancer: Targets and Therapy 2021, 13:107-132
Published Date: 24 February 2021
In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach
Fleisher B, Lezeau J, Werkman C, Jacobs B, Ait-Oudhia S
Breast Cancer: Targets and Therapy 2021, 13:87-105
Published Date: 18 February 2021
Genetic Influences in Breast Cancer Drug Resistance
Daniyal A, Santoso I, Gunawan NHP, Barliana MI, Abdulah R
Breast Cancer: Targets and Therapy 2021, 13:59-85
Published Date: 9 February 2021
The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma?
Fleury E, Nimir C, D'Alessandro GS
Breast Cancer: Targets and Therapy 2021, 13:45-58
Published Date: 15 January 2021
Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
da Silva JL, Rodrigues FR, de Mesquita GG, Fernandes PV, Thuler LCS, de Melo AC
Breast Cancer: Targets and Therapy 2021, 13:31-44
Published Date: 11 January 2021
Breast Cancer Screening Practices in a Tertiary Care Center in the State of Qatar: A Cross-Sectional Survey
Parambil JV, Najim M, Mahmoud M, Abubeker IY, Kartha A, Calaud F, Al-Mohamed A, Al-Mohannadi D, Chandra P, A Yassin M
Breast Cancer: Targets and Therapy 2021, 13:21-30
Published Date: 8 January 2021
Breast Cancer Screening Practice and Associated Factors Among Women Aged 20–70 Years in Urban Settings of SNNPR, Ethiopia
Assefa AA, Abera G, Geta M
Breast Cancer: Targets and Therapy 2021, 13:9-19
Published Date: 8 January 2021
MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients
Purwanto I, Heriyanto DS, Widodo I, Hakimi M, Hardianti MS, Aryandono T, Haryana SM
Breast Cancer: Targets and Therapy 2021, 13:1-7
Published Date: 6 January 2021